Key result
Antisense oligonucleotide-based therapies provide a customizable and rapidly deployable strategy for treating newly emerging and reemerging viral infections by targeting viral RNA.
Design
Review
Authors
Loading...
May offer a rapid-response platform for emerging viruses; leaves open clinical adoption pending prospective trials.
ASO-based therapies offer a customizable and rapidly developable approach for treating viral infections, including emerging variants.
Tarn et al. (2021) conducted a review in Viral infections. Antisense oligonucleotide (ASO)-based therapy was evaluated. Antisense oligonucleotide-based therapies provide a customizable and rapidly deployable strategy for treating newly emerging and reemerging viral infections by targeting viral RNA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: